Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 14, 2019

Derlin-1 functions as a growth promoter in breast cancer

  • Yansong Liu EMAIL logo , Ziming Wang , Handong Liu , Xin Wang , Zhonghua Zhang , Bin Xiao , Baoming An and Jun Zhang
From the journal Biological Chemistry

Abstract

Breast cancer is one of the most common malignant tumors in women. Derlin-1 has been found to be overexpressed in several human cancers in addition to playing an important role in tumor processes; however, the expression patterns and functions of Derlin-1 in human breast cancer are not fully understood. In this study, we found that Derlin-1 overexpression was higher in breast cancer compared to normal samples through TCGA and GTEx database analyses. Kaplan-Meier plotter analysis showed that Derlin-1 was a predicting factor for patient prognosis. Derlin-1 expression was significantly up-regulated in breast cancer tissues (18/30, 60.00%) compared to corresponding paracancerous tissue (9/30, 30.00%, p < 0.05) as detected by immunohistochemistry, and the expression of Derlin-1 was correlated to pathological grading. siRNA interference of Derlin-1 inhibited cell proliferation, which is associated with the promotion of apoptosis and migration. Derlin-1 knockdown suppressed the protein levels of p-AKT and Cyclin D1 while up-regulating Caspase3 and Bax. GEPIA database analysis showed that MTDH and ATAD2 were downstream target genes, and the expression of MTDH and was suppressed in Derlin-1 knockdown cells. Taken together, our results demonstrated ATAD2 that Derlin-1 is overexpressed in breast cancer and promoted a malignant phenotype through the AKT signaling pathway.

  1. Conflict of interest statement: The authors declare that they have no competing interests regarding the contents of this article.

References

Al-Zaidan, L., El Ruz, R.A., and Malki, A.M. (2017). Screening novel molecular targets of metformin in breast cancer by proteomic approach. Front. Public Health 5, 277.10.3389/fpubh.2017.00277Search in Google Scholar PubMed PubMed Central

Arcaro, A. and Guerreiro, A.S. (2007). The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. Curr. Genomics 8, 271–306.10.2174/138920207782446160Search in Google Scholar PubMed PubMed Central

Assi, H.A., Khoury, K.E., Dbouk, H., Khalil, L.E., Mouhieddine, T.H., and El Saghir, N.S. (2013). Epidemiology and prognosis of breast cancer in young women. J. Thorac. Dis. 5 (Suppl. 1), S2–8.Search in Google Scholar

Bombonati, A. and Sgroi, D.C. (2011). The molecular pathology of breast cancer progression. J. Pathol. 223, 307–317.10.1002/path.2808Search in Google Scholar PubMed PubMed Central

Caron, C., Lestrat, C., Marsal, S., Escoffier, E., Curtet, S., Virolle, V., Barbry, P., Debernardi, A., Brambilla, C., Brambilla, E., et al. (2010). Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 29, 5171–5181.10.1038/onc.2010.259Search in Google Scholar PubMed

Chen, S.F., Wu, C.H., Lee, Y.M., Tam, K., Tsai, Y.C., Liou, J.Y., and Shyue, S.K. (2013). Caveolin-1 interacts with Derlin-1 and promotes ubiquitination and degradation of cyclooxygenase-2 via collaboration with p97 complex. J. Biol. Chem. 288, 33462–33469.10.1074/jbc.M113.521799Search in Google Scholar PubMed PubMed Central

Cheng, Y.C. and Ueno, N.T. (2012). Improvement of survival and prospect of cure in patients with metastatic breast cancer. Breast Cancer 19, 191–199.10.1007/s12282-011-0276-3Search in Google Scholar PubMed PubMed Central

Cidado, J. and Park, B.H. (2012). Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy. J Mammary Gland Biol. Neoplasia 17, 205–216.10.1007/s10911-012-9264-2Search in Google Scholar PubMed PubMed Central

Dong, Q.Z., Wang, Y., Tang, Z.P., Fu, L., Li, Q.C., Wang, E.D., and Wang, E.H. (2013). Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am. J. Pathol. 182, 954–964.10.1016/j.ajpath.2012.11.019Search in Google Scholar PubMed

Dong, Q., Fu, L., Zhao, Y., Tan, S., and Wang, E. (2017). Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget 8, 17059–17069.10.18632/oncotarget.15001Search in Google Scholar PubMed PubMed Central

Feng, C., He, T., Huang, H., Qu, L., Jiang, Y., Zhang, W., and Zheng, Z. (2013). Protein globule formation in the liver graft during cold preservation for liver transplantation: its clinical and pathological significance. Open J. Pathol. 03, 119–126.10.4236/ojpathology.2013.33022Search in Google Scholar

Guo, B., Zhao, Z., Wang, Z., Li, Q., Wang, X., Wang, W., Song, T., and Huang, C. (2017). MicroRNA-302b-3p suppresses cell proliferation through AKT pathway by targeting IGF-1R in human gastric cancer. Cell. Physiol. Biochem. 42, 1701–1711.10.1159/000479419Search in Google Scholar PubMed

Hassan, B., Akcakanat, A., Holder, A.M., and Meric-Bernstam, F. (2013). Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg. Oncol. Clin. N. Am. 22, 641–664.10.1016/j.soc.2013.06.008Search in Google Scholar PubMed PubMed Central

He, D. and Zhang, S. (2018). UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway. Mol. Med. Rep. 17, 549–555.10.3892/mmr.2017.7893Search in Google Scholar PubMed

Hu, D., Ran, Y.L., Zhong, X., Hu, H., Yu, L., Lou, J.N., Sun, L.X., and Yang, Z.H. (2006). Overexpressed Derlin-1 inhibits ER expansion in the endothelial cells derived from human hepatic cavernous hemangioma. J. Biochem. Mol. Biol. 39, 677–685.10.5483/BMBRep.2006.39.6.677Search in Google Scholar

Kalashnikova, E.V., Revenko, A.S., Gemo, A.T., Andrews, N.P.,Tepper, C.G., Zou, J.X., Cardiff, R.D., Borowsky, A.D., and Chen, H.W. (2010). ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res. 70, 9402–9412.10.1158/0008-5472.CAN-10-1199Search in Google Scholar PubMed PubMed Central

Kalimuthu, S. and Se-Kwon, K. (2013). Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds. Int. J. Mol. Sci. 14, 2334–2354.10.3390/ijms14022334Search in Google Scholar PubMed PubMed Central

Katiyar, S., Joshi, S., and Lennarz, W.J. (2005). The retrotranslocation protein Derlin-1 binds peptide:N-glycanase to the endoplasmic reticulum. Mol. Biol. Cell 16, 4584–4594.10.1091/mbc.e05-04-0345Search in Google Scholar PubMed PubMed Central

Klopfleisch, R. and Gruber, A.D. (2009). Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. J. Comp. Pathol. 141, 113–120.10.1016/j.jcpa.2008.09.010Search in Google Scholar PubMed

Kusuhara, H. and Sugiyama, Y. (2007). ATP-binding cassette, subfamily G (ABCG family). Pflüger’s Archiv. 453, 735–744.10.1007/s00424-006-0134-xSearch in Google Scholar PubMed

Lilley, B.N. and Ploegh, H.L. (2004). A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429, 834–840.10.1038/nature02592Search in Google Scholar PubMed

Ma, M., Ma, Y., Zhang, G.J., Liao, R., Jiang, X.F., Yan, X.X., Bie, F.J., Li, X.B., and Lv, Y.H. (2017). Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest. Oncotarget 8, 56296–56310.10.18632/oncotarget.17626Search in Google Scholar PubMed PubMed Central

Ni, Z., Bikadi, Z., Rosenberg, M.F., and Mao, Q. (2010). Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr. Drug Metab. 11, 603–17.10.2174/138920010792927325Search in Google Scholar PubMed PubMed Central

Noguchi, K., Katayama, K., Mitsuhashi, J., and Sugimoto, Y. (2009). Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv. Drug Deliv. Rev. 61, 26–33.10.1016/j.addr.2008.07.003Search in Google Scholar PubMed

Ran, Y., Hu, H., Hu, D., Zhou, Z., Sun, Y., Yu, L., Sun, L., Pan, J., Liu, J., Liu, T., et al. (2008). Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy. Clin. Cancer Res. 14, 6538–6545.10.1158/1078-0432.CCR-08-0476Search in Google Scholar PubMed

Redig, A.J. and McAllister, S.S. (2013). Breast cancer as a systemic disease: a view of metastasis. J. Intern. Med. 274, 113–126.10.1111/joim.12084Search in Google Scholar PubMed PubMed Central

Sharma, G.N., Dave, R., Sanadya, J., Sharma, P., and Sharma, K.K. (2010). Various types and management of breast cancer: an overview. J. Adv. Pharm. Technol. Res. 1, 109–126.Search in Google Scholar

Su, P., Zhang, Q., and Yang, Q. (2010). Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue. Diagn. Pathol. 5, 38.10.1186/1746-1596-5-38Search in Google Scholar PubMed PubMed Central

Sugiyama, T., Shuto, T., Suzuki, S., Sato, T., Koga, T., Suico, M.A., Kusuhara, H., Sugiyama, Y., Cyr, D.M., and Kai, H. (2011). Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1. Biochem. Biophys. Res. Commun. 404, 853–858.10.1016/j.bbrc.2010.12.074Search in Google Scholar PubMed PubMed Central

Sun, F., Zhang, R., Gong, X., Geng, X., Drain, P.F., and Frizzell, R.A. (2006). Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. J. Biol. Chem. 281, 36856–36863.10.1074/jbc.M607085200Search in Google Scholar PubMed

Sun, G., Shi, L., Yan, S., Wan, Z., Jiang, N., Fu, L., Li, M., and Guo, J. (2014). MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells. Biomed. Res. Int. 2014, 687826.10.1155/2014/687826Search in Google Scholar PubMed PubMed Central

Takada, T., Ichida, K., Nakamura, T., Nakayama, A., Ikebuchi, Y., Ito, K., Kusanagi, Y., Chiba, T., Tadokoro, S., and Matsuo, H. (2009). Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci. Transl. Med. 1, 5ra11.Search in Google Scholar

Vivanco, I. and Sawyers, C.L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489–501.10.1038/nrc839Search in Google Scholar PubMed

Vlaming, M.L., Lagas, J.S., and Schinkel, A.H. (2009). Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv. Drug Deliv. Rev. 61, 14–25.10.1016/j.addr.2008.08.007Search in Google Scholar PubMed

Wang, J., Hua, H., Ran, Y., Zhang, H., Liu, W., Yang, Z., and Jiang, Y. (2008). Derlin-1 is overexpressed in human breast carcinoma and protects cancer cells from endoplasmic reticulum stress-induced apoptosis. Breast Cancer Res. 10, R7.10.1186/bcr1849Search in Google Scholar PubMed PubMed Central

Wang, F., Olson, E.M., and Shyng, S.L. (2012). Role of Derlin-1 protein in proteostasis regulation of ATP-sensitive potassium channels. J. Biol. Chem. 287, 10482–10493.10.1074/jbc.M111.312223Search in Google Scholar PubMed PubMed Central

Zhao, Y., Kong, X., Li, X., Yan, S., Yuan, C., Hu, W., and Yang, Q. (2011). Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One 6, e29363.10.1371/journal.pone.0029363Search in Google Scholar PubMed PubMed Central

Received: 2018-11-29
Accepted: 2019-10-08
Published Online: 2019-11-14
Published in Print: 2020-02-25

©2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.1515/hsz-2018-0442/html
Scroll to top button